deltatrials
Completed PHASE2 INTERVENTIONAL 4-arm NCT03188991

Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms

A Trial Evaluating Escalating Doses and the Safety of Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms

Sponsor: NanOlogy, LLC

Conditions Pancreatic Mucinous-Cystic Neoplasm
Interventions NanoPac®
Updated 14 times since 2017 Last updated: Jun 7, 2021 Started: Sep 29, 2017 Primary completion: Jun 29, 2020 Completion: Jun 29, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Pancreatic Mucinous-Cystic Neoplasm and is currently completed. NanOlogy, LLC leads this study, which shows 14 recorded versions since 2017 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jul 2017 – ~Oct 2017 · 3 months · monthly snapshot~Oct 2017 – ~Dec 2017 · 2 months · monthly snapshot~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Sep 2018 · 2 months · monthly snapshot~Sep 2018 – ~Feb 2019 · 5 months · monthly snapshot~Feb 2019 – ~Sep 2019 · 7 months · monthly snapshot~Sep 2019 – ~Jul 2020 · 10 months · monthly snapshot~Jul 2020 – ~Oct 2020 · 3 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Jul 2024 · 34 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Sep 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Sep 2021 [monthly]

    Completed PHASE2

  5. Oct 2020 — Jan 2021 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

▶ Show 9 earlier versions

  1. Jul 2020 — Oct 2020 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  2. Sep 2019 — Jul 2020 [monthly]

    Recruiting PHASE2

  3. Feb 2019 — Sep 2019 [monthly]

    Recruiting PHASE2

  4. Sep 2018 — Feb 2019 [monthly]

    Recruiting PHASE2

  5. Jul 2018 — Sep 2018 [monthly]

    Recruiting PHASE2

  6. Jun 2018 — Jul 2018 [monthly]

    Recruiting PHASE2

  7. Dec 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

  8. Oct 2017 — Dec 2017 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  9. Jul 2017 — Oct 2017 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • NanOlogy, LLC
  • US Biotest, Inc.
Data source: NanOlogy, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations